Anixa Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.76

-0.03 (-1.08%)

As of Sep 29, 3:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +450.0% upside

Low Target $12.50

Average Target $15.18

High Target $18.81

Current Price $2.76

Current
$2.76

Target
$15.18

$12.50 $15.18 avg $18.81

Scenario Analysis

Bear Case

$12.50

352.9%

Low target

Base Case

$15.18

+450.0%

Avg target

Bull Case

$18.81

+581.5%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$5.46

-49.4% from high

52-Week Low

$2.32

+19.0% from low

Target vs 52W High

$15.18

+178.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-26.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.2%